Publication | Closed Access

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group

Endocrine OncologyOncologyItalian TrialsPhase Ii TrialMedicinePharmacotherapyAnti-cancer AgentCancer TreatmentMedical OncologyPharmacologyCancer Research